Skip to main content

RWB Health Inc. Filed Primary

OTCQB Venture Market · First filed Feb 20, 2026 · CIK 2107166

Effective prospectus: S-1/A Apr 23, 2026 (0001477932-26-002484) · terms available

“This is a self-underwritten, direct primary offering with no minimum purchase requirement.”
Offer price
$0.03
Shares offered
3,000,000
Revenue (FY —)
Not available
Net income (FY —)
Not available

What the company does

RWB Health, Inc. is a development-stage company incorporated in Nevada on October 10, 2025, that sells CBD products in the North American marketplace. It has obtained an exclusive license to sell Natures Life CBD products in Canada, Mexico, and the United States, and non-exclusive rights to sell them globally. The company focuses on direct-to-consumer sales through its e-commerce website at www.rwbhealth.com and wholesale distribution. RWB Health has reported $8,940 in revenues and net income of $1,690 as of December 31, 2025.

Use of proceeds

The company intends to use the net proceeds from this offering to develop its business operations. To implement its plan of operations it requires a minimum of $15,000 for the next twelve months. There is no minimum number of shares that must be sold, and the company will retain the proceeds from the sale of any of the offered shares.

Underwriters

The completed effective-prospectus read stated no underwriters.

Extracted from S-1/A 0001477932-26-002484, filed Apr 23, 2026 and verified against that filing text.

Key risk factors

  • Going concern uncertainty
    “Because our auditors have issued a going concern opinion, there is an uncertainty we will continue operations, in which case you could lose your investment.”
  • Limited operating history
    “We have a limited history of operations and accordingly, there is no track record that would provide a basis for assessing our ability to conduct successful commercial activities.”
  • Need for additional capital
    “We may require additional capital in the future, and our inability to obtain such financing on favorable terms or at all could impede our growth and negatively impact our business.”
  • Regulatory changes for CBD products
    “Changes in Government policies and laws could adversely affect our business.”
  • Arbitrarily determined offering price
    “The offering price of our shares has been arbitrarily determined and may not reflect the actual value of your investment.”
  • Penny stock restrictions
    “The trading in our shares will be regulated by Securities and Exchange Commission Rule 15g-9, which established the definition of a “penny stock.””
  • Public company reporting costs
    “Becoming subject to public company reporting requirements will increase our operating expenses and could negatively impact our profitability.”

Financials before the first trade

The completed SEC companyfacts import produced no qualifying full-year financial history for this filer.

Filing history

Filed Form Accession
2026-04-23 S-1/A 0001477932-26-002484 View on EDGAR
2026-04-13 S-1/A 0001477932-26-002124 View on EDGAR
2026-03-26 S-1/A 0001477932-26-001605 View on EDGAR
2026-02-20 S-1 0001477932-26-000942 View on EDGAR

Source quotes

Offer price: “Price Per Share: $0.025”

Shares offered: “3,000,000 shares of common stock.”